RE:Survey SaysCertainly not expecting a "magic bullet" deal. So much to do in the next 3 years if they want to be revenue generating in 2026 as per analyst reports. Access to cells, instrumentation, marketing to insurance cos and govts, sales, training, manufacturing... and list goes on. And they haven't landed a single one of these deals in the past 15 months. So basically anything to get the ball rolling. Best case would be a full buyout which would resolve all issues at once... and would support the company with strong management.